RedHill Biopharma (RDHL) Return on Assets (2013 - 2024)
RedHill Biopharma's (RDHL) quarterly Return on Assets came in at 0.03% in Q4 2024, up 4.0% year-on-year from 0.03% in Q1 2024, and up 29.96% on a QoQ basis from 0.02% in Q2 2024.
RedHill Biopharma (RDHL) Return on Assets (2013 - 2024) Analysis & Trends
RedHill Biopharma (RDHL) has 12 years of Return on Assets data on file, last reported at 0.03% in Q4 2024.
- On a quarterly basis, Return on Assets rose 4.0% year-over-year to 0.03% in Q4 2024; TTM through Dec 2024 was 0.03%, a 4.0% increase from a year earlier, with the FY2025 full-year figure at 0.0%, up 1.0% from the prior year.
- Return on Assets for Q4 2024 stood at 0.03%, up from 0.02% in the prior quarter.
- Over the last five years, Return on Assets for RDHL reached as high as 0.03% in Q4 2024 and fell as low as 0.01% in Q2 2023.
- Historically, Return on Assets has averaged 0.0% across 5 years, with a median of 0.0% in 2021.
- Across the five-year window, Return on Assets fell 1 bps in 2020 and advanced 4 bps in 2024, its largest moves.
- Year by year, Return on Assets stood at 0.0% in 2020, then sank by 243 bps to 0.0% in 2021, then grew by 4 bps to 0.0% in 2022, then tumbled by 41 bps to 0.01% in 2023, then soared by 561 bps to 0.03% in 2024.
- Per Business Quant data, the three most recent Return on Assets figures were 0.03% in Q4 2024, 0.02% in Q2 2024, and 0.01% in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | 0.00% |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 0.00% |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 0.00% |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 0.00% |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 0.00% |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 0.00% |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 0.00% |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 0.00% |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 0.03% |
| Jun 30, 2024 | 0.02% |
| Dec 31, 2023 | -0.01% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2021 | 0.00% |
| Dec 31, 2020 | 0.00% |
| Sep 30, 2020 | 0.00% |
| Jun 30, 2020 | 0.00% |
| Mar 31, 2020 | 0.00% |
| Dec 31, 2019 | 0.01% |
| Sep 30, 2019 | 0.01% |
| Jun 30, 2019 | 0.01% |